Head and neck soft tissue sarcomas treated with radiation therapy

Lucas K. Vitzthum, Lindsay C. Brown, Jessica W. Rooney, Robert L. Foote

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Head and neck soft tissue sarcomas (HNSTSs) are rare and heterogeneous cancers in which radiation therapy (RT) has an important role in local tumor control (LC). The purpose of this study was to evaluate outcomes and patterns of treatment failure in patients with HNSTS treated with RT. A retrospective review was performed of adult patients with HNSTS treated with RT from January 1, 1998, to December 31, 2012. LC, locoregional control (LRC), disease-free survival (DFS), overall survival (OS), and predictors thereof were assessed. Forty-eight patients with HNSTS were evaluated. Five-year Kaplan-Meier estimates of LC, LRC, DFS, and OS were 87, 73, 63, and 83%, respectively. Angiosarcomas were found to be associated with worse LC, LRC, DFS, and OS. Patients over the age of 60 had lower rates of DFS. HNSTSs comprise a diverse group of tumors that can be managed with various treatment regimens involving RT. Angiosarcomas have higher recurrence and mortality rates. LC of soft tissue sarcomas in the extremities.3 Limited published series describe the treatment and outcome of HNSTS.2,4-19 Even fewer reports address the role of RT in HNSTS.13,15 Defining optimal management of HNSTS is further complicated by the great heterogeneity within this diverse group of tumors, which possess a range of clinical and pathologic characteristics. 2 Herein, we report the outcomes, patterns of recurrence, and potential prognostic factors in patients treated for HNSTS with RT at our institution.

Original languageEnglish (US)
Article number6165
Pages (from-to)60-65
Number of pages6
JournalRare Tumors
Volume8
Issue number2
DOIs
StatePublished - Jun 28 2016

Fingerprint

Sarcoma
Neck
Radiotherapy
Head
Disease-Free Survival
Neoplasms
Hemangiosarcoma
Survival
Recurrence
Kaplan-Meier Estimate
Treatment Failure
Mortality

Keywords

  • Angiosarcoma
  • Head and neck sarcoma
  • Radiation therapy
  • Radiotherapy
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Oncology
  • Histology

Cite this

Vitzthum, L. K., Brown, L. C., Rooney, J. W., & Foote, R. L. (2016). Head and neck soft tissue sarcomas treated with radiation therapy. Rare Tumors, 8(2), 60-65. [6165]. https://doi.org/10.4081/rt.2016.6165

Head and neck soft tissue sarcomas treated with radiation therapy. / Vitzthum, Lucas K.; Brown, Lindsay C.; Rooney, Jessica W.; Foote, Robert L.

In: Rare Tumors, Vol. 8, No. 2, 6165, 28.06.2016, p. 60-65.

Research output: Contribution to journalArticle

Vitzthum, LK, Brown, LC, Rooney, JW & Foote, RL 2016, 'Head and neck soft tissue sarcomas treated with radiation therapy', Rare Tumors, vol. 8, no. 2, 6165, pp. 60-65. https://doi.org/10.4081/rt.2016.6165
Vitzthum LK, Brown LC, Rooney JW, Foote RL. Head and neck soft tissue sarcomas treated with radiation therapy. Rare Tumors. 2016 Jun 28;8(2):60-65. 6165. https://doi.org/10.4081/rt.2016.6165
Vitzthum, Lucas K. ; Brown, Lindsay C. ; Rooney, Jessica W. ; Foote, Robert L. / Head and neck soft tissue sarcomas treated with radiation therapy. In: Rare Tumors. 2016 ; Vol. 8, No. 2. pp. 60-65.
@article{05899190c552452d8e03dab6ac8496ff,
title = "Head and neck soft tissue sarcomas treated with radiation therapy",
abstract = "Head and neck soft tissue sarcomas (HNSTSs) are rare and heterogeneous cancers in which radiation therapy (RT) has an important role in local tumor control (LC). The purpose of this study was to evaluate outcomes and patterns of treatment failure in patients with HNSTS treated with RT. A retrospective review was performed of adult patients with HNSTS treated with RT from January 1, 1998, to December 31, 2012. LC, locoregional control (LRC), disease-free survival (DFS), overall survival (OS), and predictors thereof were assessed. Forty-eight patients with HNSTS were evaluated. Five-year Kaplan-Meier estimates of LC, LRC, DFS, and OS were 87, 73, 63, and 83{\%}, respectively. Angiosarcomas were found to be associated with worse LC, LRC, DFS, and OS. Patients over the age of 60 had lower rates of DFS. HNSTSs comprise a diverse group of tumors that can be managed with various treatment regimens involving RT. Angiosarcomas have higher recurrence and mortality rates. LC of soft tissue sarcomas in the extremities.3 Limited published series describe the treatment and outcome of HNSTS.2,4-19 Even fewer reports address the role of RT in HNSTS.13,15 Defining optimal management of HNSTS is further complicated by the great heterogeneity within this diverse group of tumors, which possess a range of clinical and pathologic characteristics. 2 Herein, we report the outcomes, patterns of recurrence, and potential prognostic factors in patients treated for HNSTS with RT at our institution.",
keywords = "Angiosarcoma, Head and neck sarcoma, Radiation therapy, Radiotherapy, Soft tissue sarcoma",
author = "Vitzthum, {Lucas K.} and Brown, {Lindsay C.} and Rooney, {Jessica W.} and Foote, {Robert L.}",
year = "2016",
month = "6",
day = "28",
doi = "10.4081/rt.2016.6165",
language = "English (US)",
volume = "8",
pages = "60--65",
journal = "Rare Tumors",
issn = "2036-3605",
publisher = "PagePress",
number = "2",

}

TY - JOUR

T1 - Head and neck soft tissue sarcomas treated with radiation therapy

AU - Vitzthum, Lucas K.

AU - Brown, Lindsay C.

AU - Rooney, Jessica W.

AU - Foote, Robert L.

PY - 2016/6/28

Y1 - 2016/6/28

N2 - Head and neck soft tissue sarcomas (HNSTSs) are rare and heterogeneous cancers in which radiation therapy (RT) has an important role in local tumor control (LC). The purpose of this study was to evaluate outcomes and patterns of treatment failure in patients with HNSTS treated with RT. A retrospective review was performed of adult patients with HNSTS treated with RT from January 1, 1998, to December 31, 2012. LC, locoregional control (LRC), disease-free survival (DFS), overall survival (OS), and predictors thereof were assessed. Forty-eight patients with HNSTS were evaluated. Five-year Kaplan-Meier estimates of LC, LRC, DFS, and OS were 87, 73, 63, and 83%, respectively. Angiosarcomas were found to be associated with worse LC, LRC, DFS, and OS. Patients over the age of 60 had lower rates of DFS. HNSTSs comprise a diverse group of tumors that can be managed with various treatment regimens involving RT. Angiosarcomas have higher recurrence and mortality rates. LC of soft tissue sarcomas in the extremities.3 Limited published series describe the treatment and outcome of HNSTS.2,4-19 Even fewer reports address the role of RT in HNSTS.13,15 Defining optimal management of HNSTS is further complicated by the great heterogeneity within this diverse group of tumors, which possess a range of clinical and pathologic characteristics. 2 Herein, we report the outcomes, patterns of recurrence, and potential prognostic factors in patients treated for HNSTS with RT at our institution.

AB - Head and neck soft tissue sarcomas (HNSTSs) are rare and heterogeneous cancers in which radiation therapy (RT) has an important role in local tumor control (LC). The purpose of this study was to evaluate outcomes and patterns of treatment failure in patients with HNSTS treated with RT. A retrospective review was performed of adult patients with HNSTS treated with RT from January 1, 1998, to December 31, 2012. LC, locoregional control (LRC), disease-free survival (DFS), overall survival (OS), and predictors thereof were assessed. Forty-eight patients with HNSTS were evaluated. Five-year Kaplan-Meier estimates of LC, LRC, DFS, and OS were 87, 73, 63, and 83%, respectively. Angiosarcomas were found to be associated with worse LC, LRC, DFS, and OS. Patients over the age of 60 had lower rates of DFS. HNSTSs comprise a diverse group of tumors that can be managed with various treatment regimens involving RT. Angiosarcomas have higher recurrence and mortality rates. LC of soft tissue sarcomas in the extremities.3 Limited published series describe the treatment and outcome of HNSTS.2,4-19 Even fewer reports address the role of RT in HNSTS.13,15 Defining optimal management of HNSTS is further complicated by the great heterogeneity within this diverse group of tumors, which possess a range of clinical and pathologic characteristics. 2 Herein, we report the outcomes, patterns of recurrence, and potential prognostic factors in patients treated for HNSTS with RT at our institution.

KW - Angiosarcoma

KW - Head and neck sarcoma

KW - Radiation therapy

KW - Radiotherapy

KW - Soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84976413682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976413682&partnerID=8YFLogxK

U2 - 10.4081/rt.2016.6165

DO - 10.4081/rt.2016.6165

M3 - Article

VL - 8

SP - 60

EP - 65

JO - Rare Tumors

JF - Rare Tumors

SN - 2036-3605

IS - 2

M1 - 6165

ER -